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During angiogenesis, new blood vessel
sprouts are led by filopodia-studded tip
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enable directional migration. NRP1 is a tip
cell protein that senses angiogenic cues.
Fantin et al. now show that NRP1
promotes tip cell function by enabling
CDC42 activation for filopodia formation
and actin remodeling.
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Sprouting blood vessels are led by filopodia-studded
endothelial tip cells that respond to angiogenic sig-
nals. Mosaic lineage tracing previously revealed
that NRP1 is essential for tip cell function, although
its mechanistic role in tip cells remains poorly
defined. Here, we show that NRP1 is dispensable
for genetic tip cell identity. Instead, we find that
NRP1 is essential to form the filopodial bursts that
distinguish tip cells morphologically from neigh-
boring stalk cells, because it enables the extracel-
lular matrix (ECM)-induced activation of CDC42, a
key regulator of filopodia formation. Accordingly,
NRP1 knockdown and pharmacological CDC42 inhi-
bition similarly impaired filopodia formation in vitro
and in developing zebrafish in vivo. During mouse
retinal angiogenesis, CDC42 inhibition impaired tip
cell and vascular network formation, causing defects
that resembled those due to loss of ECM-induced,
but not VEGF-induced, NRP1 signaling.We conclude
that NRP1 enables ECM-induced filopodia formation
for tip cell function during sprouting angiogenesis.
INTRODUCTION
Developing organs, ischemic tissues, and growing tumors pro-
duce the vascular endothelial growth factor VEGF-A to signal
to its receptors on the endothelial cells (ECs) that line all blood
vessels, and the resulting angiogenic expansion of local vascu-
lature ensures the delivery of oxygen and nutrients to sustain
fundamental metabolic processes (Potente et al., 2011). VEGF-
A signaling induces both the expansion of the EC pool by
proliferation and the migration of ECs away from the existing
plexus, whereby newly formed vessel sprouts are led by special-
ized tip cells that subsequently fuse to enable the formation of
new vascular circuits (Fantin et al., 2010; Gerhardt et al., 2003;
Ruhrberg et al., 2002). The highly polarized endothelial tip cells
can be distinguished from neighboring stalk cells by clusters of
numerous long filopodia that are thought to detect microenviron-Cemental cues for directional migration (De Smet et al., 2009). Filo-
podia are highly dynamic cellular protrusions that contain parallel
bundles of filamentous actin (F-actin) and can extend from lamel-
lipodia (Mattila and Lappalainen, 2008). In addition to sensing
growth factors, filopodia can adhere to the extracellular matrix
(ECM) and form focal contacts that link the cytoskeleton to the
ECM to promote forward movement.
The main regulators of filopodia formation are members of the
RHO-GTPase family, in particular CDC42, which is activated by
VEGF-A signaling in cultured ECs (Lamalice et al., 2004).
Agreeing with a role for CDC42 in endothelial actin dynamics,
both general and endothelial-specific CDC42 deletions disrupt
blood vessel formation at the stage of vasculogenesis during
mouse development (Chen et al., 2000; Jin et al., 2013). How-
ever, the resulting early embryonic lethality of these mutants
has precluded investigations into the role of CDC42 in filopodia
formation, tip cell function, and sprouting angiogenesis in vivo.
Moreover, it is not known if VEGF-A and/or ECM cues are impor-
tant for CDC42 regulation during vessel sprouting.
Neuropilin 1 (NRP1) is a non-tyrosine kinase transmembrane
protein that regulates vascular development through dual roles
in endothelial VEGF-A and ECMsignaling (Fantin et al., 2014; Ka-
wasaki et al., 1999; Lanahan et al., 2013; Raimondi et al., 2014).
Using the mouse embryo hindbrain as a model to study physio-
logical angiogenesis, we recently demonstrated a cell-autono-
mous requirement for NRP1 in endothelial tip cells during angio-
genic sprouting (Fantin et al., 2013a). However, the specific
cellular and molecular mechanisms that depend on NRP1 in
tip cells have remainedundefined. Theprevailingmodel suggests
that NRP1 acts as a VEGFR2 co-receptor downstream of VEGF-
A signaling, which is chemotactic and induces the expression of
essential tip cell genes. Supporting this idea, NRP1 can interact
with VEGFR2 in ECs in vitro to potentiate VEGF-A signaling
(e.g., Soker et al., 2002), and tip cell identity is promoted by
VEGF-A signaling through VEGFR2 (Jakobsson et al., 2010).
Alternatively, NRP1 may modulate signal transduction pathways
that directly regulate tip cell behavior, such as cytoskeletal re-
modeling and filopodia extension. In agreement, NRP1 regulates
filopodia orientation in hindbrain blood vessels (Gerhardt et al.,
2004) and enables actin remodeling for EC migration via ABL
kinases (Raimondi et al., 2014). However, it is not known how
NRP1 might control filopodia formation and tip cell behavior.ll Reports 11, 1577–1590, June 16, 2015 ª2015 The Authors 1577
Figure 1. NRP1 Promotes Vessel Ingression Into and Growth Within the Neural Parenchyma
(A–C) PECAM immunohistochemistry of E10.5 mouse hindbrains of the indicated genotypes, flat-mounted with the ventricular side facing up; the position of
individual rhombomeres (r) is indicated. Scale bar, 500 mm. (A0–C00) Higher magnification of the boxed areas in (AC); arrowheads indicate vessels in rhombomere
boundaries.
(D–I) PECAM immunohistochemistry of E12.5 hindbrains of the indicated genotypes, flat-mounted to visualize radial (D–F) or SVP (G–I) vessels. Clear arrowheads
indicate vascular tufts and arrows vascular bridges between radial vessels in deep brain layers (below the focal plane). Scale bar, 100 mm.
(J and K) Quantitation of radial vessel (J) or SVP branchpoint (K) number at E12.5, shown as mean ± SD, nR 8 hindbrains each; asterisks indicate *p < 0.05 and
***p < 0.001.Here,wehavecombinedtheanalysisofvasculardevelopment in
themousehindbrainwith functional studies inprimary humanECs,
zebrafish embryos, and mouse retina to demonstrate that NRP1
is dispensable for the genetic specification of tip cells but essen-
tial for CDC42 activation. Unexpectedly, NRP1 enabled CDC42-
dependent actin remodeling and filopodia formation in endothelial
tip cells independently of VEGF-A stimulation, and loss of CDC42
activation did not phenocopy the vascular defects of mice with
impaired VEGF-A signaling through NRP1. Instead, NRP1-medi-
ated CDC42 activation was induced by stimulation with ECM,
and loss of this pathway caused defective vessel sprouting
and branching similar to loss of the ECM-induced, NRP1-depen-
dent activation of ABL kinases. In addition to demonstrating a
physiological role for ECM-inducedCDC42 activation in sprouting
angiogenesis, our work has therefore identified a mechanism that
ensures the integration of growth factor signals with ECM cues via
NRP1 to enable tip cell function in sprouting angiogenesis.1578 Cell Reports 11, 1577–1590, June 16, 2015 ª2015 The AuthorsRESULTS
NRP1 Promotes Vessel Ingression into and Branching
within the Neural Parenchyma
Using the mouse embryo hindbrain as a model for angiogenesis
(Fantin et al., 2013b), we have recently shown that NRP1 confers
a selective advantage to ECs competing for the tip cell position in
growing vessel sprouts (Fantin et al., 2013a). To define specific
roles for NRP1 in endothelial tip cells during angiogenesis, we
first determined the emergence and nature of vascular defects
in Nrp1-deficient mouse embryo hindbrains in greater detail
than previously done. Immunohistochemistry for the vascular
endothelial marker platelet endothelial cell adhesion molecule
(PECAM) showed that vessel ingression was mildly delayed in
hindbrains carrying one, and severely delayed in hindbrains car-
rying two, Nrp1 null alleles (Figures 1A–1C). Thus, the wild-type
subventricular vascular plexus (SVP) appeared well developed
at embryonic day 10.5 (E10.5) (Figures 1A0 and 1A00) but was less
dense in heterozygous mutants (Figures 1B0 and 1B00) and had
not formed in homozygous mutants at this stage (Figures 1C0
and 1C00). Instead, vessel growth in homozygous mutants was
largely restricted to the boundary regions between neighboring
hindbrain segments. The preferential vascularization of regions
corresponding to rhombomere boundaries may reflect their
high content of growth-factor-binding proteoglycans (Heyman
et al., 1993, 1995) and agrees with findings in zebrafish (Ulrich
et al., 2011). Importantly, heterozygous and homozygous
mutants, similar to wild-type littermates, had an average of 35
somites at E10.5, suggesting that neither were affected by a
general developmental delay at this stage. The comparison of
wild-type, heterozygous, and homozygous mutant hindbrains
therefore demonstrates a dose-dependent role for NRP1 in pro-
moting vessel ingression into neural parenchyma.
Despite the defect in subventricular zone vascularization at
E10.5, PECAM-labeled hindbrains of all genotypes had a similar
number of radial vessels at E12.5 (Figures 1D–1F and 1J). Vessel
ingression into the brain is therefore delayed in the absence of
NRP1, but not irreversibly compromised. At E12.5, heterozygous
mutants had formed an extensive SVP with a small but statisti-
cally significant reduction in branchpoints (Figures 1G, 1H, and
1K). Immunolabeling with a previously validated antibody for
NRP1 (Fantin et al., 2010) showed reduced NRP1 levels in het-
erozygous compared to wild-type brains, especially in vessel
sprouts (Figure S1, related to Figure 1), which correlated with
reduced mRNA levels (see below). In contrast to heterozygous
mutants, homozygous mutants lacked the SVP and instead
formed large vascular tufts in the subventricular zone (Figure 1I,
clear arrowheads), as previously reported (Fantin et al., 2013a;
Gerhardt et al., 2004). Even though vessels had not branched
in the appropriate plane for SVP formation, some radial vessels
branched in deeper brain layers, where they formed vascular
bridges that appeared out of focus in flat-mount preparations
(Figure 1I, arrows). Altogether, this detailed characterization of
hindbrain defects shows that NRP1 dose-dependently promotes
vessel ingression into the brain as well as subventricular zone
vascularization, two processes that specifically require angio-
genic sprout extension.
Tip Cell Filopodia Defects in Homozygous and
Heterozygous Nrp1 Null Mutants
Because NRP1 is particularly abundant on tip cell filopodia in
hindbrain ECs (Fantin et al., 2013a), we next investigated if
NRP1 deficiency affects either the formation of tip cells or their
filopodia by using high-resolution confocal microscopy of isolec-
tin B4 (IB4)-labeled E11.5 hindbrains. The wild-type hindbrain
vasculature at this stage consisted of stalk cells with scattered
filopodia and tip cells with elaborate filopodial bursts (Figures
2A and 2A0). Heterozygous mutants also formed many tip cells,
but their filopodial bursts appeared less prominent than those
of wild-type littermates (compare Figures 2A and 2A0 with Fig-
ures 1B and 1B0). Tip cells in homozygous mutants were difficult
to identify by visual inspection, as only few filopodia extended
from vessel termini, where tip cells normally reside (Figures 2C
and 2C0). Quantification established that heterozygous mutants
contained a similar density of morphologically identifiable tipCecells compared to wild-types, while homozygous mutants had
only a few obvious tip cells (Figure 2D).
Next, we adapted Imaris Filament Tracer software to automat-
ically select IB4+ filopodia extending from IB4+ vessels in the
different genotypes for quantitative analysis (Figures 2E, 2E0,
2F, and 2F0). This method demonstrated that the endothelial
filopodia number was mildly but significantly reduced in hetero-
zygous mutants and severely reduced in homozygous mutants
relative to wild-type (Figure 2G). Filopodia tracing also allowed
us to measure the dimensions of individual filopodia (Figures
2H–2I). Whereas the average filopodia length was not altered
in Nrp1 mutants (Figure 2H), the relative filopodial thickness
was significantly reduced in heterozygous andmore so in homo-
zygousmutants compared to wild-type (Figure 2I). The decrease
in filopodia number and thickness correlated with the severity of
the branching phenotype in both heterozygous and homozygous
mutants at the subsequent stage, E12.5 (see Figure 1). NRP1
mutants are therefore already compromised at the stage of
endothelial tip cell and filopodia formation, preceding the previ-
ously reported defect of NRP1 mutants in filopodia guidance
(Gerhardt et al., 2004).
NRP1 Is Dispensable for the Molecular Specification of
Tip Cells
To investigate whether defects in endothelial tip cell and filopo-
dia formation were a consequence of reduced tip cell molecular
specification, we performed qPCR of genes known to be upre-
gulated in tip cells in E11.5 hindbrains. For this analysis, we first
validated the Nrp1 knockdown in mutants and established the
expression level of Pecam relative to the housekeeping gene
Actb to provide ameasure of EC quantity. Consistent with results
obtained by immunolabeling (Figure S1, related to Figure 1),
Nrp1mRNA levels were significantly decreased in heterozygous
mutants (Figure 3A; mean fold change relative to control ± SD,
n R 3: Nrp1+/+ 1 ± 0.11, Nrp1+/ 0.63 ± 0.15; p < 0.05). As ex-
pected, Nrp1 expression was not detectable in homozygotes
due to the null mutation (Figure 3A). Correlating with decreased
Nrp1 levels and the NRP1 dose-dependent delay in brain vascu-
larization (see above),Pecam levels were significantly decreased
in both types of mutants, with a milder defect in heterozygotes
(Figure 3B; mean fold change relative to control ± SD, n R 3:
Nrp1+/+ 1 ± 0.05, Nrp1+/ 0.84 ± 0.07, Nrp1/ 0.68 ± 0.05;
p < 0.01 for Nrp1+/ and Nrp1/ relative to Nrp1+/+). Similar
results were obtained for another endothelial gene, VE-cadherin
(Cdh5;mean fold change relative to control ± SD, nR 3: Nrp1+/+
1 ± 0.11, Nrp1+/ 0.78 ± 0.16, Nrp1/ 0.69 ± 0.18; p < 0.05 for
Nrp1/ relative to Nrp1+/+).
Next, we determined the expression level of several genes
known to be upregulated in tip cells, including Apln and Ang2
(del Toro et al., 2010), Vegfr2 (Gerhardt et al., 2003), and Dll4
(Hellstro¨m et al., 2007; Lobov et al., 2007). However, none of
the tip cell markers examined showed decreased expression
in Nrp1 mutants. Thus, expression levels were similar across
all three genotypes when normalized to Actb, with the exception
of Ang2, which, rather than being decreased, was actually
significantly increased in Nrp1/ mice (mean fold change rela-
tive to control ± SD: Apln: Nrp1+/+ 1 ± 0.08, Nrp1+/ 0.9 ± 0.04,
Nrp1/ 1.13 ± 0.19, p > 0.05; Vegfr2: Nrp1+/+ 1 ± 0.13,ll Reports 11, 1577–1590, June 16, 2015 ª2015 The Authors 1579
Figure 2. NRP1 Regulates Tip Cell Morphology in a Dose-Dependent Manner
(A–C) IB4-labeled E11.5 littermate hindbrains of the indicated genotypes; green arrowheads and arrows indicate examples of tip cells and macrophages,
respectively. Scale bar, 50 mm. (A0–C0) Higher-magnification images of the boxed areas in (AC).
(D) Quantitation of tip cell number in wild-type and Nrp1 null hindbrains, shown as mean ± SD; Nrp1+/+ and Nrp1+/ n = 7 hindbrains each, Nrp1/ n = 3
hindbrains; asterisks indicate ***p < 0.001.
(E and F) Confocal z stack of a wild-type hindbrain, processed with Imaris filament tracer for filopodia analysis. In (E), the vessel plexus and filopodia are shown in
blue and red, respectively. In (F), the filopodia tracks are shown in white. (E0 and F0) Higher-magnification images of the boxed areas in (E) and (F).
(G–I) Quantitation of filopodia number, length, and thickness index with Imaris filament tracer, shown asmean ± SD, nR 3 hindbrains; asterisks indicate *p < 0.05
and ***p < 0.001.Nrp1+/ 0.9 ± 0.07, Nrp1/ 0.98 ± 0.24, p > 0.05; Dll4: Nrp1+/+
1 ± 0.11, Nrp1+/ 1.01 ± 0.13, Nrp1/ 1.04 ± 0.1, p > 0.05;
Ang2: Nrp1+/+ 1 ± 0.11, Nrp1+/ 1.01 ± 0.14, Nrp1/ 1.34 ±
0.19, p < 0.05; all p values refer to Nrp1/ relative to Nrp1+/+).
When normalized to Pecam as a measure of overall vascular
volume, the mRNA expression of all tip cell markers examined,
including that of the notch ligand DLL4, was significantly in-
creased in homozygous mutants (Figures 3C–3F). Agreeing
with increased Dll4 expression, the expression of the notch
targets Hes1 and Hey1 (Phng et al., 2009) was also slightly
increased in Nrp1 mutants (Figures 3G and 3H).
These findings suggest that NRP1 is dispensable for the ge-
netic specification of tip cells. Instead, tip cell marker expression
was upregulated in the absence of NRP1, consistent with amore
immature vessel plexus and, possibly, gene-regulatory compen-
sation for non-productive vessel sprouting.
NRP1 Is Required for ECM-Induced CDC42 Activation in
Primary Human ECs
The essential role for NRP1 in tip cell filopodia formation, but not
tip cell specification, raised the possibility that NRP1 promotes
the tip cell phenotype via CDC42, a small RHO-GTPase that
cycles between a GTP-bound active and a GDP-bound inactive1580 Cell Reports 11, 1577–1590, June 16, 2015 ª2015 The Authorsstate to regulate actin cytoskeleton reorganization, filopodia ex-
tension, and directional migration in other cell types (Heasman
and Ridley, 2008). To investigate if NRP1 promotes filopodia
extension by regulating CDC42 activation, we used primary
ECs as an in vitro model that is amenable to both cell biological
and biochemical studies. For these experiments, we chose hu-
man dermal microvascular endothelial cells (HDMECs), because
dermal vasculature naturally undergoes extensive angiogen-
esis during wound healing, and because transfection of a
previously validated small interfering RNA (siRNA) targeting
NRP1 (si-NRP1) effectively knocks down NRP1 in these cells
(Raimondi et al., 2014). To measure levels of GTP-bound (i.e.,
activated) CDC42, we used a pull-down assay with the p21-
binding domain of the p21-activated protein kinase PAK1 (Be-
nard et al., 1999). This experiment showed that stimulation
with the ECM component fibronectin (FN) for 30 min efficiently
activated CDC42 in HDMECs (Figure 4A). Moreover, ML141,
a validated allosteric inhibitor with exquisite specificity for
CDC42 over other small RHO-GTPases (Hong et al., 2013),
effectively targeted this FN-dependent CDC42 activation, con-
firming specificity of the assay (Figure 4A).
We therefore transfected HDMECs with control siRNA (si-con-
trol) or NRP1 siRNA (si-NRP1), stimulated them with FN, and
Figure 3. The Expression of Markers for Tip Cell Specification Is Not Impaired in Nrp1 Mutants
(A and B) qPCR expression analysis of Nrp1 (A) and Pecam (B), normalized to Actb in E11.5 hindbrains of the indicated genotypes (n = 4 each); expression levels
are shown as mean ± SD in mutants relative to wild-type.
(C–H) qPCR expression analysis of the indicated tip cell markers and notch target genes in E11.5 hindbrains of the indicated genotypes (n = 4 each), normalized to
Pecam to obtain an objective measure of tip cell marker expression relative to the amount of endothelium; expression levels are shown as mean ± SD in mutants
relative to wild-type.
Asterisks indicate p values for homozygous or heterozygous mutants relative to wild-type (*p < 0.05, **p < 0.01,***p < 0.001), hash tags p values for homozygous
relative to heterozygous mutants (#p < 0.05, ##p < 0.01).compared levels of total and activated CDC42 with this method.
While NRP1 knockdown did not affect the overall level of CDC42
(Figure 4B), it efficiently inhibited FN-induced CDC42 activation
(Figure 4C). Reduced CDC42 activation was also observed in
cells lacking NRP1 when VEGF-A was provided as an additional
stimulus (Figure 4D). In a parallel approach, we measured levels
of GTP-bound, activated CDC42 by performing pull-down
assays with the CDC42-binding domain of Wiskott-Aldrich syn-
drome protein (WASP) fused to glutathione S-transferase (GST)
(GST-WASP) (Kolluri et al., 1996). These experiments confirmed
that FN stimulation increases CDC42 activation in HDMECs (Fig-
ure 4E, first two lanes) and that NRP1 was required for normal
CDC42 activation after FN stimulation (Figure 4E, middle lanes),
as shown with the GST-PAK1 assay (Figure 4C). As expected,
ML141 inhibited CDC42 activation in this assay (Figure 4E,
last two lanes), similar to the GST-PAK1 assay (Figure 4A).
The quantitative analysis of GTP-bound, activated CDC42 con-
firmed that ML141 treatment significantly decreased CDC42
activation, as expected (Figure 4F, left graph; mean fold change
relative to control ± SD: control 1 ± 0.1 versus ML141 0.37 ±
0.17, p < 0.05). Moreover, there was a significant decrease
in CDC42 activation in HDMECs transfected with si-NRP1
compared to si-control cells (Figure 4F, right graph; mean fold
change relative to control ± SD: si-control 1 ± 0.11, si-NRP1
0.34 ± 0.24, p < 0.05; n = 3 independent experiments). In agree-
ment with CDC42 being regulated byNRP1, CDC42 co-immuno-
precipitated with NRP1 in HDMECs both before and during FN
stimulation (Figure 4G).
Phalloidin staining for visualization of F-actin showed thatmany
control cells after 2 hr on FN had assumed an elongated appear-Ceance with irregular edges and numerous stress fibers, typical of
motile cells (Figure 4H). In contrast, NRP1 knockdown caused
many cells to adopt a rounded morphology with few stress fibers
(Figure 4I), as previously shown (Raimondi et al., 2014). A similar
phenotype was induced by ML141-mediated CDC42 inhibition
(Figures 4J and 4K). Higher-magnification images showed that
the altered morphology of NRP1-deficient and ML141-treated
cells correlated with reduced cell protrusive activity compared
to control cells (Figures 4H0, 4I’, and 4K0). Quantitative analysis
confirmed that both NRP1 knockdown and CDC42 inhibition
significantly reduced the number of actin-positive, filopodia-like
microspikes extending from the cell periphery in HDMECs plated
on FN for 1 hr (Figures 4L and 4M).
Additional VEGF-A stimulation further increased the number
of microspikes in cells plated on FN compared to cells plated
on FN without VEGF-A stimulation (Figures 4L and 4M, compare
dark gray columns). VEGF-A addition also increased the number
of microspikes in NRP1-depleted ECs on FN (Figure 4L,
compare light gray columns). Yet, the relative reduction in the
number of microspikes between si-control and si-NRP1 cells
was similar in both FN-only and FN+VEGF conditions (Figure 4L,
red arrows). Moreover, the relative reduction in microspike
number was similar inML141-treated compared to NRP1 knock-
down HDMECs on FN (compare Figure 4L with Figure 4M). Sur-
prisingly, however, ML141 treatment was less effective than
NRP1 knockdown in reducing the microspike number of cells
plated on FN and stimulated with VEGF-A compared to cells
on FN without VEGF-A stimulation (Figure 4M). This observation
raised the possibility that VEGF-A can stimulate microspike for-
mation in both CDC42-dependent and CDC42-independentll Reports 11, 1577–1590, June 16, 2015 ª2015 The Authors 1581
Figure 4. NRP1 Is Required for Normal CDC42 Activation, and CDC42 or NRP1 Knockdown Similarly Impairs Actin Remodeling in Primary
Human ECs
(A–E) NRP1 enables ECM-induced CDC42 activation. HDMECs were serum-starved and treated with vehicle or ML141 for 30 min (A and E) or transfected with
si-control or si-NRP1 and serum starved (B–E); protein lysates of non-adherent (NA) cells or adherent cells after 30 min on FN were incubated with PAK1-GST
(A, C, and D) orWASP-GST (E, top) beads and immunoblotted or used directly for immunoblotting (B and E, bottom). In (D), HDMECs were additionally stimulated
for 15 min with 5 ng/ml VEGF165 (FN+V).
(F) Impaired CDC42 activation after ML141 treatment or NRP1 knockdown in ECM-stimulated ECs. Activated CDC42 was normalized to GST input and ex-
pressed as mean fold change relative to control ± SD; n = 3; asterisks indicate *p < 0.05.
(G) Complex formation of endogenous NRP1 and CDC42 in ECs. Lysates from NA and FN-adherent HDMECs were immunoprecipitated with control immu-
noglobulin G (IgG) or NRP1 antibody, followed by immunoblotting for NRP1 and CDC42. The 25-kDa IgG band is indicated.
(H–M) NRP1 and CDC42 are required for ECM-induced actin remodeling in ECs. After transfection with control versus NRP1 si-RNA or treatment with vehicle
versus ML141, HDMECs were detached, plated on FN for 2 hr, and stained with phalloidin to label F-actin and DAPI to visualize cell nuclei. Scale bar, 20 mm.
Higher-magnification images of the boxed areas in (H, I, and K) are shown in (H0), (I0), and (K0 ). Microspike quantitation after NRP1 knockdown (L) or CDC42
inhibition (M) and plating for 1 hr on FN, shown as meanmicrospike number per cell ± SEM; nR 42 cells for each condition (asterisks indicate p values for control
relative to si-NRP1- or ML141-treated cells: **p < 0.01, ***p < 0.001; hashtags indicate p values for FN without VEGF-A stimulation [FN] relative to cells on FNwith
additional VEGF-A stimulation [FN+VEGF], ###p < 0.001). Red arrows indicate the similar reduction in microspikes on FN compared to FN+VEGF.
(N and O) ABL1 enables CDC42 activation in ECM-stimulated ECs. After transfection with si-control or si-ABL1, lysates from NA and FN-adherent HDMECswere
incubated withWASP-GST beads followed by immunoblotting (N, top) or used directly for immunoblotting (N, bottom). GST staining and GAPDH immunoblotting
confirmed similar input of GST-beads and lysate. (O) Activated CDC42 was normalized to GST input and expressed as mean fold change relative to control ± SD;
nR 3; asterisks indicate *p < 0.05.pathways, although this idea was not investigated further in the
present study.
Taken together, our observations establish that NRP1 enables
CDC42 activation and CDC42-dependent actin dynamics and
filopodia extension in ECM-stimulated ECs, independently of
VEGF-A signaling.1582 Cell Reports 11, 1577–1590, June 16, 2015 ª2015 The AuthorsABL1 Is Required for NRP1-Dependent CDC42
Activation
The phenotype of HDMECs after CDC42 inhibition or NRP1
knockdown resembled the cellular phenotype caused by
ABL1 knockdown, including a rounded cell shape, increased
cortical actin, reduced stress fibers, and impaired microspike
formation (Raimondi et al., 2014). Moreover, similar to CDC42
activation (Figures 4C–4F), ABL1 activation depends on NRP1
in FN-stimulated ECs (Raimondi et al., 2014). We therefore
examined if ABL1 was upstream of CDC42 activation in FN-sti-
mulated ECs. For this experiment, we transfected HDMECs
with control siRNA (si-control) or siRNA targeting ABL1 (si-
ABL1), as previously shown (Raimondi et al., 2014), stimulated
the cells with FN, and then performed GST-WASP pull-down
assays for activated CDC42. This experiment demonstrated
that ABL1 loss attenuated FN-induced CDC42 activation (Fig-
ures 4N and 4O; mean fold change relative to control ± SD:
si-control 1 ± 0.28 versus si-ABL1 0.38 ± 0.2, p < 0.05; n = 3 in-
dependent experiments). ABL1 knockdown was confirmed by
reduced CRKL phosphorylation (pCRKL; Figure 4N), a known
ABL1 kinase target (Lewis et al., 1996). The similar loss of
CDC42 activation after ABL1 or NRP1 knockdown (compare
Figure 4F with Figure 4O) is consistent with the idea that
ABL1 is upstream of CDC42 activation in NRP1-mediated
ECM signaling.
Nrp1 Deficiency and Cdc42 Inhibition Similarly Impair
Vascular Sprout Extension in Zebrafish
To investigate whether NRP1 promotes the tip cell phenotype
via CDC42 in vivo and to extend our findings on NRP1 to a
model organism amenable to live imaging, we asked how
Nrp1 knockdown and Cdc42 inhibition affected angiogenesis
in the developing zebrafish trunk, where intersomitic vessels
(ISVs) sprout from the dorsal aorta and then fuse into the dorsal
longitudinal anastomosing vessels (DLAV) (Lawson and Wein-
stein, 2002). Zebrafish contain two nrp1 homologs, nrp1a
and nrp1b, and both are expressed in vascular endothelium
and reported to regulate vascular development (Bovenkamp
et al., 2004; Martyn and Schulte-Merker, 2004; Yu et al.,
2004). However, the genetic targeting of nrp1a alone was
recently suggested to not impair angiogenesis (Kok et al.,
2015). This observation implies that Nrp1a acts redundantly
with its homolog Nrp1b during ISV sprouting. We therefore
sought to downregulate both Nrp1 homologs to disrupt
Nrp1-mediated angiogenesis in zebrafish. For these experi-
ments, we used a nrp1a/b morpholino (MO) that had originally
been designed to target Nrp1 at a time when Nrp1a, but not
Nrp1b, had been identified (Hillman et al., 2011; Lee et al.,
2002) and is referred to as MO2-nrp1a in the zfin database;
however, our bioinformatics analysis predicted that this MO
might also target nrp1b (Figure 5A). To test this prediction,
we performed immunoblotting with a previously validated anti-
body that recognizes an evolutionarily conserved 14-aa region
in the cytoplasmic domain of human and mouse NRP1 (Fantin
et al., 2011). Consistent with this region being conserved in the
zebrafish Nrp1a and Nrp1b homologs (Figure 5B), this antibody
identified a band of 130 kDa corresponding to Nrp1 in protein
lysates from control fish, but not fish treated with the nrp1a/b
MO (Figure 5C).
Because Nrp1a and Nrp1b are similar in size, with 923-aa and
959-aa residues, respectively, we next separated protein lysates
from fish embryos on a gradient gel followed by immunoblotting
with the Nrp1 cytoplasmic tail antibody (Figure 5D). Using this
method, we resolved two bands at 130 kDa corresponding toCethe two Nrp1 homologs and confirmed that both proteins were
knocked down after treatment with the nrp1a/b MO (Figure 5D).
Moreover, the antibody detected only the band corresponding to
Nrp1a in size after nrp1b knockdown (Figure 5D). Agreeing with
the bioinformatics analysis, the nrp1a/bMO that is referred to as
MO2-nrp1a in the zfin database therefore targets both Nrp1a
and Nrp1b.
Having established that we could effectively downregulate
both Nrp1 homologs, we imaged the trunk vasculature of con-
trol and nrp1a/bMO-treated Tg(fli1a:EGFP)y5 embryos express-
ing a fluorescent endothelial reporter (Lawson and Weinstein,
2002) at 32 hours post-fertilization (hpf) (Figure 5E). We
observed that morphant fish lacking both Nrp1a and Nrp1b
had a similar number of ISV sprouts overall compared to control
fish (Figures 5E and 5F). However, the number of sprouts that
had reached the dorsal trunk was severely reduced in mor-
phants compared to controls and, consequently, sprouts had
not fused to form the DLAV in embryos lacking Nrp1a and
Nrp1b (Figures 5E, 5G, and 5H). In contrast, a control MO did
not affect vascular development (Figures S2A and S2B, related
to Figure 5). Moreover, the nrp1b MO alone, used at a dose
effective to knockdown the protein (Figure 5D), did not cause
severe vascular defects as in nrp1a/b MO-treated embryos
(Figure S2B, related to Figure 5), in agreement with the idea
that Nrp1a and Nrp1b have redundant functions during ISV
sprouting.
Treatment with the nrp1a/b MO increased apoptosis in the
neural tube compared to a control MO (Figure S2A, related to
Figure 5), which may be due to a neuroprotective role for Nrp1
in neural progenitors that express Nrp1a (Bovenkamp et al.,
2004; Lee et al., 2002; Martyn and Schulte-Merker, 2004; Yu
et al., 2004) and/or unspecific MO toxicity. To exclude that
neural tube apoptosis was indirectly responsible for the vascular
defect of nrp1a/b morphants, we co-injected a tp53 MO to
suppress apoptosis (Paridaen et al., 2011). As the resulting
suppression of apoptosis did not rescue the ISV defect pheno-
type of nrp1a/b morphants (Figure S2A, related to Figure 5),
the ISV defect of nrp1a/b MO-injected fish cannot be explained
by increased neural tube apoptosis. Instead, impaired ISV exten-
sion is likely caused by a cell-autonomous defect in endothelial
cells deficient in NRP1, as observed for mouse vascular devel-
opment (Fantin et al., 2013a).
Live imaging of Tg(fli1a:EGFP)y5 zebrafish embryos further
allowed us to compare the process of ISV sprouting over time
(Movies S1 and S2; Figure S3, related to the Movies S1 and S2
and Figure 5). We observed that the migration speed of ISV
sprouts was significantly reduced in embryos injected with
nrp1a/b MO compared to controls. This defect correlated with
reduced filopodia formation and dynamics, especially at the
sprout front, and, accordingly, the sprouts appeared to lack
proper tip cells (Movies S1 and S2; Figure S3, related to Movies
S1 and S2 and Figure 5). In contrast, staining for the mitotic
marker phosphorylated histone H3 (pHH3) showed that ECs still
proliferate in ISV sprouts of embryos lacking Nrp1a and Nrp1b,
excluding that impaired sprout extension is caused by defective
EC proliferation (Figure S2, related to Figure 5). The finding that
Nrp1 is required for tip-cell-led endothelial motility during ISV
sprout extension shows that NRP1’s function as a positivell Reports 11, 1577–1590, June 16, 2015 ª2015 The Authors 1583
Figure 5. Vessel Sprouting Is Compromised by Nrp1 Knockdown or Cdc42 Inhibition in Zebrafish
(A) Alignment of the nrp1a/bMO nucleotide target sequence with the 50 UTR immediately upstream of the start codon (underlined) in nrp1a and nrp1b; asterisks
indicate identical nucleotides.
(B) Alignment of the peptide sequence recognized by anti-NRP1 antibody with the cytoplasmic tail of human and mouse NRP1 as well as zebrafish Nrp1a and
Nrp1b; asterisks indicate identical amino acid residues, and the colon indicates a conservative substitution.
(C and D) Protein lysates from control and nrp1a/b and nrp1bMO-injected 32-hpf fish embryos were used for Nrp1 and Akt immunoblotting after electrophoresis
using a 10% gel (C) or 4%–12% gradient gel (D).
(E–L) Confocal z stacks of trunks from 32 hpf Tg(fli1a:EGFP)y5 zebrafish and corresponding quantitation of the indicated vascular parameters for controls versus
nrp1a/b MO (E–H) and vehicle versus ML141 treatment (I–L); scale bar, 200 mm. A kinked tail caused by Nrp1 knockdown is also seen after Cdc42 inhibition
(legend continued on next page)
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Figure 6. Cdc42 Inhibition Phenocopies Nrp1 Knockdown during Zebrafish Angiogenesis
(A and B) Imaris image analysis of ISV sprouts in nrp1morphant, ML141-treated and control embryos to determine sprout volume via surface rendering (left panel
for each condition) and filament tracing to determine sprout length (red line in the right panel for each condition) and filopodia number as well as filopodia length
(white lines). Grid ticks, 1 mm.
(C–F) Quantitative analysis of the Imaris images exemplified in (A and B) for sprout volume and sprout length (C and D), filopodia length and filopodia number
(E and F); mean ±SD, nR 8 sprouts for nrp1morphant relative to control treated fish (C and E) andML141- versus vehicle-treated fish (D and F); asterisks indicate
*p < 0.05, **p < 0.01, ***p < 0.001, and ns > 0.05.modulator of vessel sprouting is conserved between fish and
mice.
Next, we inhibited Cdc42 in Tg(fli1a:EGFP)y5 embryos by add-
ing ML141 to the aquarium water at late gastrula stage (8 hpf)
and imaged the trunk vasculature at 32 hpf (Figure 5I). Treat-
ment with 25 mM ML141 did not reduce the number of ISV
sprouts, but fewer vessels had reached the dorsal trunk than
in vehicle-treated controls, and consequently, the DLAV had
not formed at this stage (Figures 5J–5L). Treatment with
75 mM ML141 perturbed ISV formation more severely, with
slightly fewer ISV sprouts and a catastrophic failure of sprouts
to reach the dorsal trunk and form the DLAV (Figure 5I–5L), as
observed in nrp1 morphants (see Figures 5E–5H). Cdc42 inhibi-
tion therefore impairs angiogenesis in a dose-dependent
fashion. The observation that targeting Nrp1 or Cdc42 affected
sprout extension in the zebrafish trunk in a similar fashion sup-
ports the idea that both genes operate in a shared angiogenic
pathway.
We used Imaris image analysis to quantify vascular sprout de-
fects in nrp1 knockdown and ML141-treated Tg(fli1a:EGFP)y5(red arrows). Boxed areas are shown at higher magnification adjacent to each c
D indicates impaired sprout invasion into the dorsal trunk. The number of all ISV sp
laterally (H and L) is shown as mean ± SD (n R 4 fish for each treatment condit
**p < 0.01, ***p < 0.001; hashtags indicate p values for 75 mM relative to 25 mM M
Cezebrafish embryos relative to controls (Figure 6). Specifically,
we surface rendered the three most caudal ISV sprouts in each
fish embryo to determine their average volume (Figures 6A
and 6B, left panel for each condition) and applied the filament
tracer module to determine average sprout length (Figures
6A and 6B, right panel for each condition). We observed that
the total ISV sprout volumewas not affected byNrp1 knockdown
or Cdc42 inhibition but that sprout length was significantly
reduced after either treatment compared to controls (Figures
6C and 6D). Filament tracer analysis of filopodia formation
further showed that the average length of filopodia was similar
in ISV sprouts of control and treated fish but that the filopodia
number was significantly reduced after Nrp1 knockdown or
Cdc42 inhibition (Figures 6E and 6F). The similar filopodia de-
fects observed in hindbrain angiogenesis and zebrafish ISV
sprouting after NRP1 loss suggest that the tip cell role of NRP1
is conserved across vertebrate species. Genome editing in
fish to create double Nrp1a/b mutants may therefore be a
useful next step for extended analyses of NRP1 function in
angiogenesis.orresponding panel to illustrate delayed sprout extension; scale bar, 25 mm.
routs (F and J), full-length ISV sprouts (G and K), or ISV sprouts that have fused
ion). Asterisks indicate p values for nrp1a/b MO or ML141 relative to controls
L141 #p < 0.05, ###p < 0.001.
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Figure 7. CDC42 Inhibition Impairs Retinal Vessel Sprouting and Branching Similarly to ABL Inhibition but Differently to Loss of
NRP1-Dependent VEGF-A Signaling
(A–C) Comparison of retinal vascular defects after endothelial NRP1 loss or CDC42 inhibition. IB4 labeling of P6 retinal vasculature from littermate Nrp1fl/fl mice
lacking Cre (n = 8) or expressing Pdgfb-iCre-ERT2-Egfp (n = 6) after daily tamoxifen injection from P2 to P5 (A) or from littermate wild-type mice treated daily from
P2 to P5 with vehicle (n = 3) or ML141 (n = 4) (B). In (A), retinas were co-immunolabeled for NRP1 to demonstrate knockdown in mutants. (C) Quantification of
filopodial bursts at the vascular front and branchpoints behind the vascular front; mean ± SD; asterisks indicate *p < 0.05, **p < 0.01, and ***p < 0.001.
(D and E) Comparison of retinal vascular defects after ABL kinase inhibition or loss of VEGF-A binding to NRP1. IB4 labeling of P6 retinal vasculature
from littermate wild-type mice treated daily from P2 to P5 with vehicle or Imatinib (D) or Nrp1Y297A/Y297A mice lacking VEGF-A binding to NRP1 and wild-type
littermates (E).
For (A), (B), (D), and (E), the top panels show low-magnification images of retinal flat mounts (scale bar, 1 mm) and boxed areas are shown at higher magnification
below each panel (scale bar, 200 mm). The green arrow indicates normal vascular extension, the red arrows defective vascular extension, and the arrowheads
abnormally long and wide sprouts without lateral protrusions or connections.
(F) Schematic representation of NRP1 roles in angiogenesis. NRP1 enables the ECM-dependent activation of ABL1 andCDC42 in addition to its classical role as a
VEGFR2 co-receptor in VEGF-A signaling.CDC42 Inhibition Impairs Retinal Angiogenesis Similarly
to Loss of ECM Signaling through NRP1
To provide additional, genetic evidence for the role of NRP1 in
CDC42 activation during angiogenesis, we also compared the
vascular phenotypes of mice treated with ML141 or carrying a
genetic mutation that disrupts endothelial NRP1 expression.
For these experiments, we used the mouse retina as a model
of NRP1-dependent angiogenesis (1) because it is accessible
to small-molecule inhibitors and suited to the tamoxifen-induc-
ible, endothelial specific deletion of floxed target genes and (2)
because this model was recently used to establish distinct roles
for ECM-induced and VEGF-A-induced NRP1 pathways in
angiogenesis (Fantin et al., 2014; Gelfand et al., 2014; Raimondi1586 Cell Reports 11, 1577–1590, June 16, 2015 ª2015 The Authorset al., 2014). To obtain endothelial Nrp1 mutants defective in
both ECM and VEGF-A signaling, we used mice with conditional
Nrp1 null (floxed) alleles (Nrp1fl/fl) expressing a tamoxifen-induc-
ibleCre transgene under the control of the endothelialPdgfb pro-
moter (Pdgfb-iCreER-Egfp) or littermate controls lacking the Cre
transgene (Fantin et al., 2013a; Raimondi et al., 2014). Tamoxifen
treatment from perinatal day 2 (P2) to P5 efficiently knocked
down NRP1 in the mutant compared to littermate control retina
at P6 (Figure 7A). As previously shown (Raimondi et al., 2014),
NRP1 knockdown reduced vascular network density, with
sprouts at the vascular front appearing longer and larger and
fewer lateral connections between neighboring vessels (Fig-
ure 7A, red arrowhead).
Similar to NRP1 knockdown, CDC42 inhibition with ML141
from P2 to P5 reduced vascular network density at P6, with
sprouts at the vascular front appearing longer and larger and
fewer lateral connections between neighboring vessels (Fig-
ure 7B, red arrowhead). Quantitative analysis demonstrated a
significant reduction in tip cell density at the vascular front in
both NRP1-targeted and ML141-treated P6 retinas (Figure 7C).
The number of vascular branchpoints, formed through the
fusion of newly formed vessel sprouts, was also severely
reduced after both NRP1 targeting and ML141 treatment (Fig-
ure 7C). Accordingly, retinas of NRP1-ablated and ML141-
treated mice had a similarly reduced vascular complexity. As
previously shown (Raimondi et al., 2014), the inhibition of ABL
kinases, which operate downstream of ECM-induced NRP1
signaling in retinal angiogenesis, caused sparser and longer
sprouts at the vascular front and reduced vascular network
complexity in the P6 retina (Figure 7D) similar to the pharmaco-
logical inhibition of CDC42 (Figure 7B). The observation that
targeting NRP1, ABL kinases, or CDC42 similarly affects the
filopodia-led processes of vascular sprouting and branching in
the retina supports the idea that these genes operate in a
shared angiogenic tip cell pathway.
Endothelial NRP1 loss also severely inhibited vascular ex-
tension (Figure 7A, red arrow) (Raimondi et al., 2014). This
phenotype was not observed after CDC42 inhibition (Figure 7B,
green arrow; mean distance from the optic nerve head to the
vascular front relative to the retinal radius ± SD: vehicle 0.78 ±
0.05 versus ML141 0.81 ± 0.03; n R 3 each; p > 0.05). This
finding suggests that NRP1 also has CDC42-independent roles
in angiogenesis. In agreement, abolishing VEGF-A binding to
NRP1 in Nrp1Y297A/Y297A mice (Fantin et al., 2014) recapitulated
the vascular extension defect caused by endothelial NRP1 loss
in the P6 retina (Figure 7E, red arrow). Vice versa, vascular
branching, which was severely compromised by endothelial
NRP1 loss, ABL inhibition or CDC42 inhibition, was only mildly
affected inNrp1Y297A/Y297AP6 retinas (Figure 7E). Taken together
with our in vitro studies in HDMECs, we conclude that NRP1 has
multiple roles in angiogenesis, which include the ECM-depen-
dent activation of both ABL kinases and CDC42 in addition to
NRP1’s classical role as a VEGFR2 co-receptor in VEGF-A
signaling (Figure 7F).
DISCUSSION
Angiogenic vessel growth depends on the formation of new
sprouts composed of endothelial tip and stalk cells, followed
by the fusion of nascent sprouts into perfused circuits. Previ-
ously, we demonstrated that NRP1 promotes the function of
tip cells, even though we had not identified the specific molec-
ular mechanism involved (Fantin et al., 2013a). Now, we show
that NRP1 stimulates tip cell behavior by enhancing endothelial
actin remodeling and filopodia extension, which agrees with the
observed enrichment of NRP1 on tip cells and their filopodia
(Fantin et al., 2013a). Filopodia are particularly important for
directional cell migration through their roles in sensing chemo-
tactic and haptotactic cues in the extracellular environment;
they also act as anchorage points for ECM attachment, likely
generating tension to pull cells forward as they become motileCe(De Smet et al., 2009). During retinal angiogenesis, vessel
sprouts headed by filopodia-studded tip cells migrate toward
astrocyte-localized VEGF-A in the retinal periphery (Gerhardt
et al., 2003; Ruhrberg et al., 2002), with filopodia being guided
by astrocyte-derived FN (Raimondi et al., 2014; Stenzel et al.,
2011). The process of VEGF-A/ECM-driven radial migration is
accompanied by lateral branching and sprout fusion to add
perfused loops to the expanding vessel network. With its dual
role in VEGF-A and ECM signaling, demonstrated clearly for
retinal angiogenesis (Figure 7) (Fantin et al., 2014; Gelfand
et al., 2014; Raimondi et al., 2014), NRP1 may therefore
be exquisitely poised to help translate microenvironmental
cues into regulated actin dynamics for EC migration during
blood vessel sprouting. However, NRP1 clearly acts in concert
with other guidance pathways, as sprouting angiogenesis is
compromised, but not abolished, by NRP1 ablation. The finding
that NRP1 mutants with impaired filopodia formation show de-
layed, but not absent, vessel migration (Figures 1, 2, 5, and 7)
agrees with prior observations in zebrafish, which showed that
vascular sprout extension, even though inefficient, can still
take place when filopodia formation is inhibited (Phng et al.,
2013).
Morphologically identifiable tip cells were rare in Nrp1 null
mouse hindbrains (Figure 2), raising the possibility that NRP1
either controls tip cell specification or enables the execution
of the tip cell cytoskeletal program. We observed that NRP1
targeting did not reduce the expression of genes known to be
upregulated in tip cells and commonly used as tip cell markers
(Figure 3). NRP1 is therefore not required for the genetic spec-
ification of tip cells. Rather than decreasing the expression of
tip cell genes, NRP1 loss increased the expression of these
genes, including Vegfr2 (Figure 3). In agreement with increased
Vegfr2 expression, we observed increased expression of Dll4,
a tip cell gene that is induced by VEGF-A signaling through
VEGFR2 during tip cell selection (Jakobsson et al., 2010),
arguing against defective VEGFR2 signaling as the cause of
vascular defects in Nrp1 null hindbrains. Moreover, consistent
with increased Dll4 expression, the notch target genes Hes1
and Hey1 were upregulated (Figure 3). The observation that
the network of known tip cell markers and their targets is prin-
cipally intact and in fact upregulated rather than downregulated
may be a reflection of the more immature vessel plexus in Nrp1
null mutants (Figure 1). Nevertheless, the upregulation of the
tip cell specification program is unable to compensate for
the sprouting defect in Nrp1 null mutants, arguing for a major
morphological defect that prevents proper execution of tip
cell behavior.
CDC42 is a key mediator of filopodia assembly and actin re-
modeling in many cell types (De Smet et al., 2009) and is acti-
vated downstream of VEGF-A signaling in cultured ECs (Lama-
lice et al., 2004). Experiments with the embryoid body model of
vasculogenesis had suggested that CDC42 is essential for blood
vessel assembly by vasculogenesis, which takes place prior to
angiogenesis (Qi et al., 2011). However, the early embryonic
lethality of both constitutive and endothelial-specific CDC42
knockout mice due to defective vasculogenesis (Chen et al.,
2000; Jin et al., 2013) had previously precluded the investiga-
tion of CDC42 in tip cell function and therefore sproutingll Reports 11, 1577–1590, June 16, 2015 ª2015 The Authors 1587
angiogenesis in themouse. We have circumvented this limitation
by targeting CDC42 activation with the allosteric inhibitor. We
observed that CDC42 inhibition impaired ECM-induced actin
cytoskeleton remodeling and the extension of filopodia-like mi-
crospikes in human ECs in vitro as well as endothelial filopodia
extension and vessel branching during angiogenesis in mice
and fish in vivo (Figures 4, 5, 6, and 7). Similar phenotypes
were observed after endothelial NRP1 knockdown, consistent
with our finding that NRP1 is required for CDC42 activation in
ECs (Figure 4).
Strikingly, CDC42 inhibition affected retinal angiogenesis
similarly to inhibiting ABL kinases (Figure 7), which are activated
in a NRP1-dependent fashion after stimulating ECs with FN.
Thus, we have previously shown that ABL1 knockdown in pri-
mary human ECs or treatment of perinatal mice with the ABL
kinase inhibitor Imatinib impaired ECM-induced and NRP1-
dependent actin cytoskeleton remodeling, filopodia extension,
and vessel branching in ECs (Raimondi et al., 2014). Interest-
ingly, prior observations had suggested that ABL kinases func-
tion upstream of CDC42 in myeloid cells after lysophosphatidic
acid stimulation (Baruzzi et al., 2010). In agreement, we found
that ABL1 is also required for CDC42 activation in ECM-stimu-
lated ECs (Figure 4). As ABL1 forms a complex with NRP1 (Rai-
mondi et al., 2014), and NRP1 forms a complex with CDC42
(Figure 4G), it is likely that the NRP1/ABL1 complex has a direct
role in CDC42 activation, perhaps by localizing CDC42 to sites
of actin remodeling. Additionally, a small but significant
decrease in NRP1 protein levels caused by ABL1 knockdown
(Raimondi et al., 2014) may also contribute to reduced CDC42
activation. In either scenario, the surprising similarity of pheno-
types caused by ABL or CDC42 inhibition distinguishes ECM-
induced NRP1 signaling functionally from VEGF-A-induced
NRP1 signaling, which instead appears to be more important
for chemotactic guidance and vascular extension (Figure 7),
likely by potentiating VEGFR2 signaling in both tip and stalk
cells (e.g., Gerhardt et al., 2003).
In summary, our findings show that NRP1 enables actin re-
modeling and filopodia formation in endothelial tip cells via
CDC42 to help convert proangiogenic ECM signals into tip
cell responses for directional vessel sprouting and branching
(summarized in Figure 7F). This model differs substantially from
prior models, which suggested that NRP1 functions mainly as
a co-receptor for VEGFR2, another known tip cell gene, to
enable VEGF-A mediated chemotactic guidance. Thus, both
NRP1 functionsmay cooperate to ensure that angiogenic growth
factor guidance and ECM-stimulated migration are coordinated
to ensure the ordered vascularization of developing organs
(model in Figure 7F).
The similar angiogenesis defects caused by loss of NRP1 in
genetically targeted mice and MO-treated fish, together
with the similarity to defects induced by pharmacological
CDC42 inhibition in both species and also in human endothelial
cells, argue that the mechanism of NRP1-mediated CDC42
regulation is conserved across species. In addition to its prom-
inent role in endothelial cells, NRP1 is also expressed in cell
types as diverse as neurons, immune cells, and tumor cells.
Future work should therefore investigate whether NRP1-
dependent CDC42 activation contributes to physiological or1588 Cell Reports 11, 1577–1590, June 16, 2015 ª2015 The Authorspathological contexts beyond its essential role in develop-
mental angiogenesis.
EXPERIMENTAL PROCEDURES
Mouse Strains
Animal procedures were performed in accordance with institutional and UK
Home Office ethical guidelines. For more information, see the Supplemental
Experimental Procedures.
Whole-Mount Immunolabeling, Imaging, and Quantitative Analysis
of Mouse Hindbrains and Retinas
Mouse embryo hindbrains and postnatal retinas were immunolabeled as
described previously (Fantin et al., 2013b; Pitulescu et al., 2010). For the 3D
analysis of EC filopodia morphology with Imaris (BitPlane), IB4+ blood vessels
and macrophages in high-resolution confocal z stacks were masked, but filo-
podia extending from vessels were excluded from the mask; filopodia were
automatically tracked with the Imaris Filament Tracer module. For more infor-
mation, see the Supplemental Experimental Procedures.
Gene Expression Analyses
Hindbrain mRNA was extracted using TRI reagent (Sigma-Aldrich) and cDNA
prepared using Superscript III reverse transcriptase (Invitrogen) for qRT-PCR
using SYBR Green (Applied Biosystems). For more information, see the Sup-
plemental Experimental Procedures.
Zebrafish
MOs were injected into Tg(fli1a:EGFP)y5 (Lawson and Weinstein, 2002) or
Tg(kdrl:HsHRAS-mCherry)s896 (Chi et al., 2008) zebrafish embryos at the
one-cell stage. Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/)
was used to align nucleotide and amino acid sequences. Formore information,
see the Supplemental Experimental Procedures.
Cell Culture and Cell Imaging
HDMECs were cultured in MV2 media with supplements (Promocell) and
transfected with SMARTpool siRNA targeting NRP1 or ABL1 (Dharmacon) or
Silencer negative control siRNA (Applied Biosystems) using Lipofectamine
RNAIMAX (Life Technologies). For more information, see the Supplemental
Experimental Procedures.
CDC42 Pull-DownAssay, Immunoprecipitation, and Immunoblotting
GTP-bound CDC42 was isolated with glutathione agarose beads bound to the
p21-binding domain of PAK1 (Millipore) or the CDC42-binding domain of
WASP (Cytoskeleton) via a GST tag and identified by immunoblotting of eluted
proteins with an antibody for CDC42 (Millipore). For more information, see the
Supplemental Experimental Procedures.
Statistical Analysis
We calculated p values with a two-tailed unpaired Student’s t test or one-way
ANOVA followed by a Tukey post hoc test with Prism 5 (GraphPad Software) or
Excel 12.2.6 (Microsoft Office); p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.05.018.
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